
Doctor Mariana Brandao
Hospital Universitario Puerta De Hierro Majadahonda, Madrid (Spain)
Membership:
ESC Professional Member
EACVI Member
Biography
Mariana Brandão is a Portuguese cardiologist currently working in Madrid, Spain. She completed her Cardiology Residency at Gaia Hospital Center in Portugal, where she co-founded the center’s Cardiomyopathy Program. She also trained at the Cardiomyopathy Unit of Careggi University Hospital in Florence, Italy, under the guidance of Prof. Iacopo Olivotto. Her clinical activity has also focused on cardiovascular imaging, specifically echocardiography and cardiac magnetic resonance imaging.
Mariana Brandão is currently a research and clinical fellow at the Inherited Cardiac Diseases Unit at Hospital Universitário Puerta de Hierro Majadahonda. She is also a PhD student, with a project primarily focused on cardiac amyloidosis, under the supervision of Prof. Pablo Garcia Pavia.
Within the ESC, Mariana is a member of the Heart Imagers of Tomorrow and the Web and Communication Committees of the EACVI. She has been involved in ESC social media activities since 2023.
Contributor content
Presentation
'Jeopardy!' - ESC Global Cardiology Edition - Team 'Heart Attackers'
Presentation
Digital follow-up program for patients undergoing atrial fibrillation ablation: a pilot single-center study
Presentation
Echocardiographic assessment of the right heart in patients with aortic stenosis undergoing transcatheter aortic valve implantation: analysis from a large single-center cohort
Presentation
Sex differences in aortic stenosis progression and myocardial response
Presentation
Recognizing HCM and HF: making the diagnosis
Presentation
A middle-age diagnosis of apical hypertrophic cardiomyopathy: there is more than meets the eye
Presentation
A double menace in the heart: concomitant left atrial and left ventricular masses
Presentation
Right heart echocardiographic parameters and outcomes of patients with aortic stenosis after transcatheter aortic valve implantation
Presentation
Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort
Presentation

